What is Codexis Inc?
provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 110.69M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 424,409 shares $31k | 0 |
| 3-6months | 12,605 shares $6k | 0 |
| 6-9months | 15,862 shares $7k | 0 |
| 9-12months | 10529,170 shares $899k | 0 |